CTRI/2020/07/026555
Completed
未知
Active Safety surveillance study in pediatric patients of Childhood onset Nephrotic Syndrome on Rituximab therapy
INSTITUTIONAL RESEARCH FUND0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N041- Nephrotic syndrome with focal andsegmental glomerular lesions
- Sponsor
- INSTITUTIONAL RESEARCH FUND
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Diagnosed cases of childhood onset nephrotic syndrome \<\=18 years of age, of any gender, who have either received at least one dose of RTX in the last 3 months or shall receive rituximab in our hospital.
- •2\.Subjects willing to give written informed consent and comply with study related instructions
Exclusion Criteria
- •1\.Subjects unwilling to give written informed consent and comply with study related instructions.
- •2\.Subjects on rituximab therapy for any non\-renal indications.
- •3\.Subjects who have received the last dose of RTX more than 3 months back.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Surveillance towards preventing RSV respiratory infection in paediatricsISRCTN41075797iverpool School of Tropical Medicine2,074
Recruiting
Not Applicable
Pediatric Alarm Study For Physiologic Monitoring in General WardJPRN-UMIN000033727Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center400
Terminated
Not Applicable
Surveillance Study of Patients With Newly Diagnosed OsteosarcomaOsteosarcomaNCT01194284Millennium Pharmaceuticals, Inc.25
Completed
Not Applicable
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors.Malignant gliomasRPCEC00000183Centro de Inmunología Molecular (CIM)160
Recruiting
Not Applicable
A prospective observational study in child patients with RSV infectioRSV infectionJPRN-jRCT1030230252Ishiwada Naruhiko100